GEMPHARMATECH

GemPharmatech is a global contract research organization that provides comprehensive preclinical research services and over 25,000 genetically engineered mouse models, including KO, cKO, humanized, immunodeficient mice & more. We support drug discovery through custom model generation, breeding, and compound efficacy testing in China & the U.S., advancing research worldwide. | GemPharmatech is a leading contract research organization that provides genetically engineered mouse models (GEMMs) and services to global preclinical R&D communities. We specialize in developing animal models using cutting edge gene-editing technologies with a large collection of cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice. GemPharmatech provides an expansive array of preclinical services, including mouse model customization, pharmacology services such as drug efficacy testing and mouse phenotyping, CRISPR/Cas9 gene-editing, cryopreservation, rapid expansion, and customized breeding. The GemPharmatech contract research organization has developed one of the world's largest collections of mouse models to enable scientific innovation and accelerate drug development.

Exhibited at: 2023 BIO International Convention, AACR Annual Meeting 2026